Overview of Skin Cancers for General Practitioners

Tarek Haykal

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

Imaging Considerations for the Dermatologist

Masterclasses in Dermatology

C. Bakewell

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

Melanoma Brain Metastases: Successes, Failures, and Future Opportuni…

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

M. Postow

Understanding Treatment Sequencing in Metastatic Melanoma: IO vs. Ta…

Vanderbilt University Medical Center (VUMC)

D. Johnson

How to Manage: Melanonychia

EADV 2022 Conference Coverage

M. Starace

Nivolumab + Relatlimab in the Treatment Landscape of Metastatic Mela…

Piotr Rutkowski

Promoting Skin Self-Exam for the Secondary Prevention of Melanoma

David Polsky

Increasing Melanoma Incidence with Unchanged Mortality, 1999 - 2019

Jesper Bo Nielsen

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

Year in Review: Surgical Treatment of Acral Melanoma

2023 Year in Review

M. Leventer

Frontline Treatment Decisions in Metastatic Melanoma

Eric Whitman

Medical Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

ESMO 2024 Insights: Nivo + Ipi ± ASTX727 in Anti-PD-1 Resistant Meta…

2024 ESMO Annual Meeting Insights Hub

A. Di Giacomo